• Subscribe
  • Newsfeed
  • About
  • Jobs
Announce News

M&G Investments

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technologybit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology
    bit.bio
    10 Jan 2026

    bit.bio announces £40m Series C from M&G Investments to pioneer human cell programming technology

    bit.bio develops human cell programming technology that produces consistent, scalable human cells for research, drug discovery and toxicology, helping pharmaceutical and biotech companies reduce reliance on animal testing and improve predictive accuracy.

M&G Investments
    • Life Sciences
  • 1(12 months)
  • mandg.com/investments/gb
  • Update Information

More venture news

  • Nscale raises £1.5bn Series C led by Aker ASA and 8090 Industries to deploy AI infrastructure globally
    Nscale
    9 Mar 2026

    Nscale raises £1.5bn Series C led by Aker ASA and 8090 Industries to deploy AI infrastructure globally

    Series CAI
  • Automata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI models
    Automata
    29 Jan 2026

    Automata raises £33m Series C led by Dimension to build the operating layer between physical labs and AI models

    Series CLife Sciences
  • KKR leads £300m Series C for Lighthouse to accelerate AI-driven growth in the hospitality tech market
    Lighthouse
    21 Nov 2024

    KKR leads £300m Series C for Lighthouse to accelerate AI-driven growth in the hospitality tech market

    Series CHospitality

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn